211 related articles for article (PubMed ID: 31194767)
21. [The different experession of human papilloma viral types 6 and 11 in Uyghur and Chinese juvenile recurrent respiratory papillomatosis in a large pediatric population in Xinjiang].
Zainura A; Yalkun Y; Wu M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1205-7. PubMed ID: 24617003
[TBL] [Abstract][Full Text] [Related]
22. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.
Lacey CJ; Lowndes CM; Shah KV
Vaccine; 2006 Aug; 24 Suppl 3():S3/35-41. PubMed ID: 16950016
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
24. A case for immunization of human papillomavirus (HPV) 6/11-infected pregnant women with the quadrivalent HPV vaccine to prevent juvenile-onset laryngeal papilloma.
Shah KV
J Infect Dis; 2014 May; 209(9):1307-9. PubMed ID: 24265442
[TBL] [Abstract][Full Text] [Related]
25. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.
Novakovic D; Cheng AT; Cope DH; Brotherton JM
Sex Health; 2010 Sep; 7(3):253-61. PubMed ID: 20719212
[TBL] [Abstract][Full Text] [Related]
26. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and HPV type in recurrent respiratory papillomatosis in Colombia.
Cuello G; Sánchez GI; Jaramillo R; Quintero K; Baena A; O'Byrne A; Reyes AJ; Santamaría C; Reina JC; Muñoz N
Salud Publica Mex; 2013 Aug; 55(4):416-20. PubMed ID: 24165718
[TBL] [Abstract][Full Text] [Related]
28. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus.
Hawkes M; Campisi P; Zafar R; Punthakee X; Dupuis A; Forte V; Ford-Jones EL
Pediatr Infect Dis J; 2008 Feb; 27(2):149-54. PubMed ID: 18174855
[TBL] [Abstract][Full Text] [Related]
29. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
30. Nucleotide and phylogenetic analysis of human papillomavirus types 6 and 11 isolated from recurrent respiratory papillomatosis in Brazil.
de Matos RP; Sichero L; Mansur IM; do Bonfim CM; Bittar C; Nogueira RL; Küpper DS; Valera FC; Nogueira ML; Villa LL; Calmon MF; Rahal P
Infect Genet Evol; 2013 Jun; 16():282-9. PubMed ID: 23466889
[TBL] [Abstract][Full Text] [Related]
31. Molecular subtypification of human papillomavirus in male adult individuals with recurrent respiratory papillomatosis.
García-Romero CS; Akaki-Caballero M; Saavedra-Mendoza AG; Guzmán-Romero AK; Canto P; Coral-Vázquez RM
Auris Nasus Larynx; 2015 Oct; 42(5):385-9. PubMed ID: 25906915
[TBL] [Abstract][Full Text] [Related]
32. Presenting Symptom as a Predictor of Clinical course in Juvenile Onset Recurrent Respiratory Papillomatosis.
Mudd P; Wikner E; Rana MS; Zalzal G
Laryngoscope; 2021 Jul; 131(7):1670-1675. PubMed ID: 33331659
[TBL] [Abstract][Full Text] [Related]
33. Novel HPV-6 variants of human papillomavirus causing recurrent respiratory papillomatosis in southern Africa.
Combrinck CE; Seedat RY; Randall C; Roodt Y; Burt FJ
Epidemiol Infect; 2012 Jun; 140(6):1095-101. PubMed ID: 21875449
[TBL] [Abstract][Full Text] [Related]
34. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
[TBL] [Abstract][Full Text] [Related]
35. FRET-based detection and genotyping of HPV-6 and HPV-11 causing recurrent respiratory papillomatosis.
Combrinck CE; Seedat RY; Burt FJ
J Virol Methods; 2013 May; 189(2):271-6. PubMed ID: 23473839
[TBL] [Abstract][Full Text] [Related]
36. Recurrent respiratory papillomatosis in northern Sweden: clinical characteristics and practical guidance.
Loizou C; Laurell G; Arvidsson A; Lindquist D; Nylander K; Olofsson K
Acta Otolaryngol; 2015; 135(10):1058-64. PubMed ID: 26004132
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
Szeps M; Dahlgren L; Aaltonen LM; Öhd J; Kanter-Lewenshon L; Dahlstrand H; Munck-Wikland E; Grandér D; Dalianis T
J Gen Virol; 2005 Jun; 86(Pt 6):1695-1702. PubMed ID: 15914847
[TBL] [Abstract][Full Text] [Related]
38. Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years.
Kocjan BJ; Gale N; Hočevar Boltežar I; Seme K; Fujs Komloš K; Hošnjak L; Maver PJ; Jelen MM; Zupanič Pajnič I; Balažic J; Poljak M
J Infect Dis; 2013 Feb; 207(4):583-7. PubMed ID: 23204170
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis.
Maloney EM; Unger ER; Tucker RA; Swan D; Karem K; Todd NW; Reeves WC
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):711-5. PubMed ID: 16847177
[TBL] [Abstract][Full Text] [Related]
40. A retrospective case-control analysis of the efficacy of Gardasil
Milner TD; Harrison A; Montgomery J; MacGregor FB; Buchanan MA; MacKenzie K
Clin Otolaryngol; 2018 Jun; 43(3):962-965. PubMed ID: 29380936
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
